GlassScriptPhysician profile
Carrie L Shulman
NPI 1225017833
$54,019.10
in general payments reported to CMS, 2019-2025
31 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $3,230 · 2020: $212 · 2021: $16K · 2022: $9,870 · 2023: $2,950 · 2024: $9,558 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $5,788 · Food and Beverage: $2,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,750.00 |
| Travel and Lodging | $5,787.52 |
| Food and Beverage | $2,494.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Choice Spine, LLC | $23,343.59 | 2023-2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Stratofuse, Blackhawk Cervical Spacer System |
| Integrity Implants INC. | $13,502.89 | 2021-2022 | |
| Mirus, LLC | $5,527.70 | 2022 | |
| Stryker Corporation | $2,438.90 | 2019-2022 | |
| Globus Medical, INC. | $2,305.95 | 2021-2025 | Senza, Nvm5 |
| Spine Wave, INC. | $2,105.13 | 2022 | |
| Medtronic, INC. | $1,205.33 | 2021-2025 | Mazor X System, Kyphon Express II Kyphopak Tray, Stealthstation S8 Platform |
| Si-Bone, INC. | $687.37 | 2019-2020 | |
| Providence Medical Technology, INC. | $586.23 | 2022-2025 | |
| Gt Medical Technologies, INC | $330.06 | 2021-2025 | Gammatile |
| Kuros Biosciences USA, INC | $237.79 | 2023-2024 | Magnetos |
| Theragen, INC. | $214.35 | 2021-2024 | Actastim-S |
| Intrinsic Therapeutics | $173.86 | 2021-2025 | Barricaid Acd (Annular Closure Device) |
| Bioventus LLC | $152.71 | 2022-2024 | Bonescalpel & Sonicone (O.R.) |
| Abbott Laboratories | $137.24 | 2019-2025 | Eterna |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $129.91 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $124.93 | 2019 | |
| Integra Lifesciences Corporation | $118.18 | 2019-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Depuy Synthes Sales INC. | $112.91 | 2021-2023 | Teligen, Neuroscout |
| Boston Scientific Corporation | $99.89 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Coastal Medical Technologies LLC | $85.29 | 2024 | |
| Monteris Medical Corporation | $77.15 | 2019-2022 | |
| Nevro Corp. | $64.55 | 2019 | |
| Orthofix Medical, INC. | $62.62 | 2019-2024 | Cervical-Stim |
| Ctl Medical Corporation | $38.00 | 2022 | |
| Innovasis INC | $36.28 | 2023 | |
| Flowonix Medical Incorporated | $36.00 | 2020 | |
| Arteriocyte Medical Systems, INC. | $33.81 | 2021-2025 | Magellan |
| Smith+Nephew, INC. | $28.49 | 2021-2022 | |
| Spineology INC. | $21.99 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,280.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Shulman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.